Klencke Barbara 4
4 · eFFECTOR Therapeutics, Inc. · Filed Jan 24, 2023
Insider Transaction Report
Form 4
Klencke Barbara
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-20+28,125→ 28,125 totalExercise: $0.47Exp: 2033-01-19→ Common Stock (28,125 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in substantially equal monthly installments over 12 months, commencing on January 20, 2023, subject to the Reporting Person's continued service with the Issuer through each vesting date.